Cisatracurium Besylate Injection

Product description

Cisatracurium is used adjunctively inanesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
Strength: 10mg/5ml; 200mg/20ml (10mg/ml).

This product has been approved by CFDA, and files have been submitted to multiple authorities of various countries for approval. It is the one of key products in our company’s anaesthetic products’ line. It was submitted to US FDA and approved in 2017.

Cisatracurium Besylate Injection (preservatived)Strength:  20mg/10ml---US ANDA is available.
Read more

Specifications

Categories Finished Dosage FormsInjectables; Finished Dosage Forms
Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America

More products from Jiangsu Hengrui Medicine Co., Ltd.

View all our products (78)

Products from other suppliers

Cisatracurium Besylate Injection

Contact information

Address

Telephone

Website

View all contact information